Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Wantz1, M"'
Autor:
Wantz, M., Chekkat, N., Bouché, M., Dahm, G., Bellemin-Laponnaz, S., Fournel, S., Wantz1, M, Chekkat1, N, Bouche´, M, Dahm2, G, Kichler, A., Frisch, B., Bellemin-Laponnaz2, S, Fournel1, S
Publikováno v:
European Journal of Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S31-S32, ⟨10.1016/j.ejca.2019.01.094⟩
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer
6tth International Cancer Immunotherapy Conference in Europe (ITOC) Apr 11-13, 2019 Vienna, AUSTRIA Cancer Drug Dev Forum; Soc Immunotherapy Cancer, 2019, Vienna, Austria. pp.S31-S32, ⟨10.1016/j.ejca.2019.01.094⟩
International audience; Background: Platinum (II)-based drugs are widely used chemother-apeutic agents. However, as they have many side effects, numerous platinum (Pt) derivatives have been developed during the last years. Furthermore, some cancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b6f713bec396c53fb6e7898f54add3
https://hal.archives-ouvertes.fr/hal-02347590/document
https://hal.archives-ouvertes.fr/hal-02347590/document